Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fluvoxamine-tricyclic antidepressant interaction. An accidental finding.

Literature DB >> 1905641

Fluvoxamine-tricyclic antidepressant interaction. An accidental finding.

G Bertschy, S Vandel, B Vandel, G Allers, R Volmat.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1991 PMID： 1905641 DOI： 10.1007/bf00315151

Source DB: PubMed Journal: Eur J Clin Pharmacol ISSN： 0031-6970 Impact factor: 2.953

× No keyword cloud information.

6 in total

Review 1. Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.

Authors: P Benfield; A Ward
Journal: Drugs Date: 1986-10 Impact factor: 9.546

2. Interaction between amitriptyline and phenothiazine in man: effect on plasma concentration of amitriptyline and its metabolite nortriptyline and the correlation with clinical response.

Authors: B Vandel; S Vandel; G Allers; P Bechtel; R Volmat
Journal: Psychopharmacology (Berl) Date: 1979-10 Impact factor: 4.530

3. Behavioral and cognitive toxicity related to elevated plasma tricyclic antidepressant levels.

Authors: J H Meador-Woodruff; M Akil; R Wisner-Carlson; L Grunhaus
Journal: J Clin Psychopharmacol Date: 1988-02 Impact factor: 3.153

4. Relationship between the plasma concentration of clomipramine and desmethylclomipramine in depressive patients and the clinical response.

Authors: B Vandel; S Vandel; J M Jounet; G Allers; R Volmat
Journal: Eur J Clin Pharmacol Date: 1982 Impact factor: 2.953

5. Valpromide increases the plasma concentrations of amitriptyline and its metabolite nortriptyline in depressive patients.

Authors: S Vandel; G Bertschy; J M Jounet; G Allers
Journal: Ther Drug Monit Date: 1988 Impact factor: 3.681

6. Review of the animal pharmacology and pharmacokinetics of fluvoxamine.

Authors: V Claassen
Journal: Br J Clin Pharmacol Date: 1983 Impact factor: 4.335

6 in total

26 in total

1. An interaction between carbamazepine and fluvoxamine.

Authors: V Martinelli; A Bocchetta; A M Palmas; M Del Zompo
Journal: Br J Clin Pharmacol Date: 1993-12 Impact factor: 4.335

2. Inhibitors of imipramine metabolism by human liver microsomes.

Authors: E Skjelbo; K Brøsen
Journal: Br J Clin Pharmacol Date: 1992-09 Impact factor: 4.335

Review 3. The impact of the CYP2D6-polymorphism on dose recommendations for current antidepressants.

Authors: Norbert Thuerauf; Jens Lunkenheimer
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2006-08 Impact factor: 5.270

Review 4. Pharmacokinetics of haloperidol: an update.

Authors: S Kudo; T Ishizaki
Journal: Clin Pharmacokinet Date: 1999-12 Impact factor: 6.447

Review 5. Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects.

Authors: J L Pilgrim; D Gerostamoulos; Olaf H Drummer
Journal: Forensic Sci Med Pathol Date: 2010-11-04 Impact factor: 2.007